Diabetic Nephropathy (DN) is a microvascular complication of insulin dependent (IDDM) and non-insulin dependent (NIDDM) diabetes mellitus characterised by persistent proteinuria, decline in glomerular filtration rate (GFR) and increased morbidity and mortality in diabetics[@CIT1]. Studies have suggested that the prevalence of DN is approximately 40% in diabetic patients[@CIT2]. DN is the most common cause of end stage renal disease (ESRD)[@CIT3]. Physicians face challenges in selecting, initiating and individualising appropriate drug therapy for patients with DN.

The study of prescribing patterns is a component of medical audit that monitors and evaluates prescribing practices and recommends necessary modifications to achieve rational drug use[@CIT4]. The objective of this study was to analyse current drug prescribing trends in the management of DN in hospitalised patients undergoing tertiary care.

This prospective, cross sectional, observational study was conducted in the inpatient ward of the Nephrology Department of a tertiary care teaching hospital over the six-month period, 1^st^ October 2003 to 31^st^ March 2004. All inpatients with the diagnosis of DN made by the consultant nephrologist, undergoing treatment in the Nephrology unit were included. However, patients who were under day care and those who were admitted only for dialysis were excluded. Patients to be included in the study were identified while accompanying the physicians on morning rounds and the diagnosis was confirmed from the inpatient medical records. The demographic details, necessary clinical data and drug details were collected in a specially designed proforma. This study included only one prescription per patient during that hospital stay.

Drugs were classified into different groups based on Anatomic Therapeutic Chemical (ATC) classification[@CIT5]. World Health Organization (WHO) recommends this classification system developed by European Association for Pharmaceutical Market and International group. In the ATC classification system, the drugs are divided in to different groups according to the organ system on which they act and or therapeutic and chemical characteristics. These classifications are from the WHO\'s collaborating Centre for Drug Statistics methodology. Data on utilization of different classes as well as individual drugs were subjected to descriptive analysis.

Of 637 inpatients admitted in the Nephrology ward during the study period, 102 (16%) were found to have DN. The male to female ratio was 2:1. The mean age for developing DN was 55.1±9.5 years. The mean age among males was 54.5±8.75 years and that for females was 55.7±10.1 years.

One hundred patients were diagnosed with NIDDM while two patients were found to have IDDM. Ninety-five patients (93%) suffered from chronic renal failure being either in stage 4 (overt nephropathy) or in stage 5 (ESRD) of DN. The rest were found to be in the stage of micro-albuminuria (stage 3 of DN). Of known risk factors for the development of DN, male gender (67%), family history of DN (12%), diabetes of more than ten years duration (76%), were observed. Hypertension and diabetic retinopathy was found in all patients (100%). The results of analysis of prescriptions for rationality are presented in [Table 1](#T0001){ref-type="table"}. Drugs were categorised into 14 groups based on first anatomical level of ATC classification[@CIT5] as shown in [Table 2](#T0002){ref-type="table"}.

###### 

ANALYSIS OF PRESCRIPTIONS IN DIABETIC NEPHROPATHY

  Details of prescription                                                                Number (%)
  -------------------------------------------------------------------------------------- ------------
  Total number of prescriptions analysed                                                 102
  Total number of drugs prescribed                                                       755
  Average number of drugs per prescription                                               7.4
  Number of drugs from WHO essential drug list out of total number of drugs prescribed   401 (53)
  Number of drugs prescribed by generic name out of total number of drugs prescribed     90 (12)
  Total number of injections out of total number of drugs                                242 (32)

###### 

DISTRIBUTION OF DRUGS IN DIFFERENT CATEGORIES BASED ON ATC CLASSIFICATION PRESCRIBED IN DIABETIC NEPHROPATHY

  Drug class (based on ATC classification)                                 Number N=755   Percentage
  ------------------------------------------------------------------------ -------------- ------------
  A - Drugs for Gastro-intestinal tract and metabolism                     281            37\. 2
  B - Drugs for treatment of disorders of blood and blood forming organs   70             9.3
  C - Drugs for Cardiovascular system                                      211            27.9
  D - Dermatological drugs                                                 4              0.5
  G - Drugs for Genitourinary systems and sex hormones                     27             3.6
  H - Hormones for systemic use except sex hormones                        4              0.5
  J - Anti-infectious drugs for systemic use                               77             10.2
  L - Antineoplastic and Immunomodulating agents                           3              0.4
  M - Drugs for Musculoskeletal systems                                    5              0.7
  N - Drugs acting on Nervous System                                       14             1.8
  P - Drugs against parasites and insecticides                             0              0
  R - Drugs for Respiratory system                                         42             5.6
  S - Drugs for eye and ear                                                3              0.4
  V - Various others                                                       14             1.9

Based on ATC classification, it was found that drugs acting on gastrointestinal system and metabolism and cardiovascular drugs represented the maximum in patients with diabetic nephropathy.

The most frequently prescribed drug classes in DN were presented in [Table 3](#T0003){ref-type="table"}. Antihypertensives were prescribed to all study patients. Amlodipine (68/74; 91.89%) was the most commonly prescribed calcium channel blocker, while furosemide (49/53; 92.45%) and prazosin (40/41; 97.56%) topped the list of diuretics and alpha-blockers respectively. Twenty eight percent of the prescriptions contained a single antihypertensive drug, while 61% contained two and 11% contained three. Of the total of 102 prescriptions, 49% contained one antimicrobial drug, 9.8% had two drugs and 5.9% had three drugs. Omeprazole (25/70; 35.7%), and pantoprazole (13/70; 18.6%) accounted for more than half the total anti-peptic ulcer prescriptions. Preparations of insulin accounted for the majority of hypoglycemic drugs (91%) as illustrated in [Table 2](#T0002){ref-type="table"}.

###### 

PATTERNS OF UTILIZATION OF MAJOR DRUG CLASSES

  Drug class                                      [\*](#T000F1){ref-type="table-fn"}ATC code   Number   Percentage
  ----------------------------------------------- -------------------------------------------- -------- ------------
  Antihypertensive drugs (n=186)                                                                        
    1. Calcium channel blockers                   C08CA                                        74       40
    2. Diuretics                                  C03CA                                        53       28
    3. Alpha blockers                             C02CA                                        41       22
    4. Angiotensin converting enzyme inhibitors   C09AA                                        7        4
    5. Beta blockers                              C07AB                                        5        3
  6\. Miscellaneous group                                                                      6        3
  Antiinfective drugs (n=77)                                                                            
    1. Quinolones                                 J01MA                                        28       36
    2. Cephalosporins                             J01DA                                        21       27
    3. Metronidozole                              G01AF01                                      11       14
    4. Miscellaneous group                                                                     17       22
  Antipeptic ulcer drugs (n=70)                                                                         
    1. Proton pump inhibitors                     A02BC                                        38       54
    2. H2 blockers                                A02BA                                        28       40
    3. Miscellaneous group.                                                                    4        6
  Hypoglycaemic drugs (n=69)                                                                            
    1. Insulin                                    A10A                                         63       91
    2. Oral hypoglycaemic drugs                   A10B                                         6        9

Anatomic-Therapeutic-Chemical classification

The five most frequently prescribed agents were amlodipine (68/755) (9%), calcium carbonate (54/755) (7.2%), furosemide (49/755) (6.5%), prazosin (40/755) (5.3%) and ranitidine 28/755 (3.7%). Analysis of the different routes of administration used for 755 drugs showed that 470 (62%) drugs were administered orally, 181 (24%) by intravenous or intramuscular route, 58 (8%) by subcutaneous route for, 25 (3%) by inhalation and 21 (3%) by other routes.

The results of our study revealed that the percentage of in-patients who were treated in Nephrology ward with the diagnosis of DN was 16% of the total number of hospitalised patients in the Nephrology unit over six months. The demographic results revealed that there was a male preponderance with the mean age above 50 years as similar to a previous Indian study conducted by John *et al*.[@CIT6].

The analysis of clinical data showed that the majority of study patients were type 2 diabetics. Known risk factors seen in the present study included male sex, long duration of diabetes (more than 10 years), family history of DN and hypertension[@CIT7]. Hypertension and diabetic retinopathy were the two associated major co-morbid factors of DN seen in 100% of patients. The majority of patients (93%) were in late stage of DN (stage 4 or 5) with chronic renal failure.

The average number of drugs per prescription was 7.4, indicating polypharmacy. In research studies, polypharmacy has been defined as the concomitant use of five or more drugs[@CIT8]. Generally, a finding of polypharmacy is an indication that there is scope for review of the existing prescribing trends. However, given the distinctive health problems of this particular study population, it is a moot point whether use of five concomitant drugs can be considered to be polypharmacy. Our study thus highlights the issue of definition of polypharmacy for DN with multiple co-morbid factors. This is of vital importance given that polypharmacy requires justification because of the increased risk of drug interactions and errors of prescribing[@CIT9].

In this study it was found that only 12% of the drugs were prescribed by generic name, showing that prescribing by brand name is the norm. Fifty three percent of the prescribed drugs were from the WHO essential drugs list[@CIT10]. Around 32% of the total numbers of drugs were given as injections, which are a commonly overused and costly form of drug therapy.

The results of this study showed that people with DN are in need of a wide spectrum of drug classes under ATC classification. The most commonly prescribed therapeutic classes (based on ATC classification) in DN were drugs for gastrointestinal system and drug metabolism (A) (39.7%), drugs for cardio-vascular system (C) (27.9%) and antiinfectives for systemic use (J) (10.2%). Comparative clinical trials and pharmacoeconomic analysis of different drugs from these classes will be highly beneficial for patients with DN.

Analysis of prescribing pattern of antihypertensives revealed that calcium channel blockers (C08CA) (46.3%) and diuretics (C03CA) (26%) were the most frequently prescribed anti-hypertensive drugs to treat hypertension in DN. ACE inhibitors and alpha-receptor blockers (ARBs) reduce the progression of DN and should be preferred in individuals with diabetes plus microalbuminuria[@CIT11]. However, in late stages of DN with chronic renal failure or ESRD, hyperkalemia is more likely to develop when ACE inhibitors are prescribed. Also, unlike CCBs, most of the ACE inhibitors need dose modification in renal failure[@CIT12]. Hyperkalemia produced by ARBs is comparable to that produced by ACE inhibitors in the presence of renal insufficiency or diabetes[@CIT11]. As the majority (93%) of patients in this study were in late stages of DN with chronic renal failure or ESRD, the choice of CCBs and diuretics is logical.

The fact that 100% of study patients were on antihypertensive medication is an indication of the high prevalence of cardiovascular morbidity in DN[@CIT1]. Further, about 72% of patients were prescribed more than one antihypertensive drug. The seventh report of the Joint National Committee (JNC VII) also has reported that combinations of 2 or more drugs are needed to achieve the target blood pressure of 130/80 mm of hg in diabetic hypertensive patients[@CIT11].

Insulin was highly preferred over oral hypoglycaemic drugs. It is well established that intensive glycaemic control reduces the rate and progression of micro-albuminuria in diabetics. However, during the phase of declining renal function, insulin requirement falls since the kidney is a site of insulin degradation[@CIT12] and this could be the reason for the striking number (37%), of such patients not receiving any anti-diabetic agent.

Prescriptions of insulin preparations (91%) were more compared to OHAs. This transfer to insulin treatment could be due to avoidance of oral hypoglycaemic drugs, which can accumulate in uraemia and lead to hypoglycaemia[@CIT13]. In this study, about 65% of 102 patients received anti-microbial agents which indicated the high prevalence of infections in patients hospitalised with DN.

Of 755 drugs, the top three most commonly prescribed drugs in this study were amlodipine (9%), calcium carbonate (7.2%) and furosemide (6.5%). The high use of amlodipine and furosemide is unsurprising as all patients had concomitant hypertension. High usage of calcium carbonate is explained by the need for phosphate binders in renal failure. The oral route (62.3%) was the most commonly prescribed route of drug delivery even in hospitalized patients with DN.

This study identified a wide variety of classes of drugs prescribed in DN. This was indicative of the wide spectrum of prevailing morbidity patterns in patients with this chronic disease. Inpatient based prescription audit has a major advantage of minimising the 'drop-outs' because patient compliance is ensured. The information on drug prescribing patterns can provide a framework for continuous prescription audit in a hospital setting. This can help the prescribers to improve patient management by rationalising prescribing practices.
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